Amgen to sponsor Golden Ticket award at BioLabs LA

By The Science Advisory Board staff writers

February 4, 2021 -- Amgen is sponsoring a three-year Golden Ticket award at BioLabs LA at the Lundquist Institute in West Carson, CA, to support the development of new therapies, medical devices, and diagnostics.

The winner of the award will be able to use laboratory space shared by BioLabs and the Lundquist Institute, which will allow for access to laboratory infrastructure, programming, and business development mentoring, Amgen said.

Amgen supports life science startups through Golden Ticket awards in other cities such as Boston, San Francisco, and Toronto, according to the firm.

Astellas announces 'golden ticket' winners
Astellas Venture Management, a subsidiary of Astellas Pharma and LabCentral, announced that Axonis Therapeutics and Tenza are the 2020 winners of the...
Astellas, MBC BioLabs call for scientists to enter 'Golden Ticket Competition'
Astellas Venture Management and Mission Bay Capital BioLabs (MBC BioLabs) are collaborating again on the "Golden Ticket Competition," which offers up...
Amgen, Eli Lilly to scale up manufacturing of COVID-19 antibody therapies
Eli Lilly and Amgen will collaborate on global antibody manufacturing to significantly increase the supply capacity of Lilly's potential COVID-19 therapies.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter